Optimal Stent Deployment Strategy of Contemporary Stents
NCT05292651 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 248
Last updated 2024-02-01
Summary
The primary objective is to evaluate whether a standard pre- and postdilatation (PSP strategy) of the modern DES results in a more optimal stent implantation compared to DS as evaluated by OCT in patients with stable coronary artery disease. The secondary clinical objective is to evaluate clinical cardiovascular outcomes in patients with stable coronary artery disease treated with the PSP strategy.
Conditions
Interventions
- PROCEDURE
-
PCI
percutaneous coronary intervention
Sponsors & Collaborators
-
Albert Schweitzer Hospital
lead OTHER
Principal Investigators
-
Rohit Oemrawsingh, MD, PhD · Albert Schweitzer Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-09-01
- Primary Completion
- 2027-09-01
- Completion
- 2029-09-01
Countries
- Netherlands
Study Locations
More Related Trials
-
Bare -Metal Stents and Drug -Eluting Stents in the Treatment of Patients With Vertebral Artery Ostium Stenosis
NCT02197559 ·Status: COMPLETED
-
Clinical Performance of CRE8 Drug Eluting Stent in All Comer Population
NCT01556126 ·Status: COMPLETED ·Phase: NA
-
Critical Treatment of Coronary Artery Disease
NCT03195621 ·Status: COMPLETED ·Phase: NA
-
the Effect of Prolonged Inflation Time During Stents Deployment for ST-elevation Myocardial Infarction
NCT03199014 ·Status: UNKNOWN ·Phase: NA
-
Joint Inflation With Nominal-pressure and Stability Approach in DES Optimization
NCT06013007 ·Status: COMPLETED ·Phase: NA
-
Retrospective Study of the Impact of Drug Eluting Stents
NCT00487604 ·Status: UNKNOWN
-
Prospective Assessment of Efficacy and Safety of Drug Eluting Stents
NCT02313038 ·Status: COMPLETED
-
Bioabsorbable Versus Durable Polymer Drug Eluting Stent (DES): a Meta-analysis
NCT01466634 ·Status: COMPLETED
-
Study of Oral Rapamycin Plus Bare Metal Stents vs Drug Eltuting Stents
NCT00552669 ·Status: COMPLETED ·Phase: PHASE4
-
Intracoronary Stenting and Restenosis - Randomized Trial of Drug-eluting Stent Implantation or Drug-coated Balloon Angioplasty According to Neointima Morphology in Drug-eluting Stent Restenosis 5
NCT05544864 ·Status: RECRUITING ·Phase: NA
-
Post-dilatation for Optimization of Drug-eluting Stents (DES) Deployment Assessed by Intravascular Ultrasound Multicenter Analysis
NCT01103765 ·Status: UNKNOWN ·Phase: PHASE4
-
Serial OCT Evaluation of Tissue Coverage in Patients Submitted to Inspiron Drug Eluting Stent Implantation
NCT03269461 ·Status: COMPLETED ·Phase: NA
-
The Direct III Post Market Study
NCT02693158 ·Status: COMPLETED
-
MULTIcentric BElgium/NEtherlands PRO-Kinetic Safety and Efficacy Study
NCT01531725 ·Status: COMPLETED ·Phase: NA
-
The COOPerative Establishment for Necessary Investigation in Clinical Outcome After Stenting
NCT01534221 ·Status: UNKNOWN ·Phase: PHASE4
-
Reduced Stent Strategy Versus Conventional Percutaneous Coronary Revascularization in Patients Presenting With STEMI
NCT06353594 ·Status: RECRUITING ·Phase: NA
-
Genetics Study of In-stent Restenosis
NCT01670396 ·Status: UNKNOWN
-
Procedural Advantages of a Novel Drug-Eluting Coronary Stent
NCT02881216 ·Status: COMPLETED ·Phase: NA
-
Vascular Healing of DES at 3 Months
NCT01391871 ·Status: COMPLETED
-
Efficacy Study of Drug-eluting and Bare Metal Stents in Bypass Graft Lesions
NCT00611910 ·Status: COMPLETED ·Phase: PHASE4
-
DUrable Polymer-based STent CHallenge of Promus Element Versus ReSolute Integrity in an All Comers Population
NCT01331707 ·Status: COMPLETED ·Phase: PHASE4
-
Matrix Metalloproteinases Expression in the Neointimal Hyperplasia Induced by Drug Eluting Stent (DES) Implantation
NCT03375528 ·Status: UNKNOWN ·Phase: NA
-
Impact of Stent Length and Diameter on Patients Undergoing Primary PCI
NCT04110691 ·Status: UNKNOWN
-
DUrable Polymer-based STent CHallenge of Promus ElemEnt Versus ReSolute Integrity
NCT02175706 ·Status: UNKNOWN ·Phase: NA
-
Intra-stent Tissue Evaluation Within BMS and DES > 3 Years Since Implantation
NCT01835301 ·Status: UNKNOWN